Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Cohort Study to Assess the Risk of Autoimmune Diseases in Adolescent and Young Adult Women Aged 9 to 25 Years Exposed to Cervarix® in the United Kingdom

NCT01953822 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01953822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01953822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Cohort Study to Assess the Risk of Autoimmune Diseases in Adolescent and Young Adult Women Aged 9 to 25 Years Exposed to Cervarix® in the United Kingdom
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
August 31, 2014
Enrollment
1,053 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus